Influenza A pandemic (H1N1) 2009 virus infection

Chinese Medical Journal

Volumn 124, Issue 20, 2011, Pages 3399-3402

  Bai, Lu ^a   Cao, Bin ^a   Wang, Chen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

H1N1 subtype; Influenza a virus; Pathology; Pneumonia; Risk factors; Viral

Indexed keywords

AMANTADINE; CORTICOSTEROID; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIVIRAL RESISTANCE; ARTICLE; AUTOMUTILATION; AUTOPSY; BACTERIAL INFECTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DISEASE ASSOCIATION; DISEASE SEVERITY; DISORIENTATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FATALITY; GEOGRAPHIC DISTRIBUTION; HALLUCINATION; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LUNG INFILTRATE; MENTAL DISEASE; MIXED INFECTION; MORTALITY; NAUSEA; NONHUMAN; PANDEMIC INFLUENZA; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY TRACT INTUBATION; RISK ASSESSMENT; RISK FACTOR; SEPTIC SHOCK; THORAX RADIOGRAPHY; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS SHEDDING; VOMITING;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; PNEUMONIA; RISK FACTORS;

EID: 80054863211     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.20.034     Document Type: Article

References (26)

1. Pandemic H1N1 in China. Updated December 2009. Ministry of Health of the People's Republic of China, 2009. (Accessed January 2, 2010 at http://www.moh.gov.cn/publicfiles/ business/htmlfiles/mohwsyjbgs/s7863/201001/45434.htm.)
2. Cao B, Li XW, Shu YL, Jiang N, Chen SJ, Xu XY, et al. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus, People's Republic of China. Emerg Infect Dis 2009; 15: 1418-1422.
3. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, et al. Clinical features of the initial influenza A H1N1 2009 cases in China. N Engl J Med 2009; 61: 2507-2517.
4. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1) v in Spain. Crit Care 2009; 13: R148.
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935-1944.
6. Denholm JT, Gordon CL, Johnson PD, Hewagama SS, Stuart RL, Aboltins C, et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. Med J Aust 2009; 192: 84-86.
7. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302: 1896-1902.
8. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect 2010; 60: 168-174.
9. Ajlan AM, Quiney B, Nicolaou S, Muller NL. Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings. AJR Am J Roentgenol 2009; 193: 1494-1499.
10. Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. AJR Am J Roentgenol 2009; 193: 1488-1493.
11. Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361: 1925-1934.
12. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009; 302: 1872-1879.
13. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302: 1880-1887.
14. Miller RR III, Markewitz BA, Rolfs RT, Brown SM, Dascomb KK, Grissom CK, et al. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest 2010; 137: 752-758.
15. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-689.
16. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic infuenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 1071-1074.
17. Several and fatal cases of influenza A (H1N1) infection in China. Ministry of Health of the People's Republic of China, 2009. (Accessed September 9, 2009 at: http://www. moh.gov.cn/publicfiles/business/htmlfiles/mohbgt/s3582/2009 12/44871.htm.).
18. Mauad T, Hajjar LA, Callegari GD, da Silva LF, Schout D, Galas FR, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010; 181: 72-79.
19. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009; 339: b5106.
20. Li IW, Hung IF, To KK, Chan KH, Wong SS, Chan JF, et al. The natural viral load profile of patients with pandemic 2009 influenza A (H1N1) and the effect of oseltamivir treatment. Chest 2010; 137: 759-768.
21. World Health Organization (WHO). Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. (Accessed November 2009 at http://www.who.int/ csr/resources/publications/swineflu/clinical_management_h1 n1.pdf.)
22. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, Kaewchana S, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4: e6051.
23. World Health Organization (WHO). Pandemic (H1N1) 2009. update 91. Virological surveillance data. (Accessed March 12, 2010 at http://www.who.int/csr/disease/swineflu/laboratory 12_03_2010/en/index.html.)
24. Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, et al. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008; 31: 1097-1114.
25. Nakamura K, Schwartz BS, Lindegardh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clin Infect Dis 2010; 50: e47-e49.
26. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888-1895.